title: Hepatitis B surface antigen seroreversion in a T-cell lymphoma patient.
authors.forename: Hsuan-Wei
authors.initials: HW
authors.lastname: Chen
authors.forename: Shine-An
authors.initials: SA
authors.lastname: Lin
authors.forename: Hsin-Chung
authors.initials: HC
authors.lastname: Lin
authors.forename: Woei-Yau
authors.initials: WY
authors.lastname: Kao
mesh_terms: D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D001219:Aspartate Aminotransferases / Q000097:blood; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D006147:Guanine / Q000031:analogs & derivatives / Q000627:therapeutic use; D006509:Hepatitis B / Q000097:blood* / Q000188:drug therapy / Q000209:etiology; D006514:Hepatitis B Surface Antigens / Q000097:blood*; D006515:Hepatitis B virus / Q000276:immunology*; D006801:Humans; D016399:Lymphoma, T-Cell / Q000097:blood* / Q000150:complications / Q000821:virology; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D014750:Vincristine / Q000627:therapeutic use; D014775:Virus Activation / Q000187:drug effects*
chemical_list: D000998:Antiviral Agents; D006514:Hepatitis B Surface Antigens; C413685:entecavir; D014750:Vincristine; D006147:Guanine; D004317:Doxorubicin; D003520:Cyclophosphamide; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D011241:Prednisone